Search

everythinglearnresearchcommunity

for

Search:↓

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Melatonin may protect against cell damage in pancreatitis.

Spironolactone is an effective and safe treatment for acne in adult women.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Antiandrogens are used to manage polycystic ovary syndrome by reducing androgen levels or controlling their effects, often combined with lifestyle changes and other treatments.

Blocking the ATX-LPA pathway may improve insulin sensitivity and mitochondrial function in obesity.

The conclusion is that healthcare professionals should report adverse drug reactions to improve medication safety and patient care.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Finasteride weakens the bone-protective effects of certain blockers in low androgen conditions.

Drugs like PDEI may help hair disorders like AGA.

DACC-based dressings are more effective than silver-based ones for treating chronic wounds with antimicrobial resistance.

Peripheral blood alive cell treatment is effective and safe for treating hair loss.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

Some bacteria use arsenic compounds as antibiotics, and others have evolved resistance; a particular arsenic-based compound shows potential as a new antimalarial treatment.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Most adverse reactions to the treatment were mild, with nausea being the most common.